Skip to search formSkip to main contentSkip to account menu

BL 3459

Known as: BL-3459 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1981
1981
Comparison of sulfinpyrazone and BL-3459 with S - 20344, a potent new antithrombotic agent.
1979
1979
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
1979
1979
Antiplatelet drugs and the generalized Shwartzman reaction in the pregnant rat.
Several antiplatelet drugs (aspirin, sulfinpyrazone, hydroxychloroquine, dipyridamole, BL-3459, pyridinolcarbamate) were assayed… 
1977
1977
Enhanced platelet aggregability in dogs following myocardial infarction.
1976
1976
The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs.
1975
1975
Pharmacology of a potent, new antithrombotic agent, 6-methyl-1,2,3,5-tetrahydroimidazo[2, 1-b] quinazolin-2-one hydrochloride monohydrate.
The effect of 6-methyl-1,2,3,5-tetrahydroimidazo[2,1-b] quinazolin-2-one hydrochloride monohydrate (BL-3459) on platelet function… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)